Share chart Comera Life Sciences Holdings, Inc.
Extended chart
Simple chart
About Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. more detailsIPO date | 2022-05-19 |
---|---|
ISIN | US20037C1080 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://comeralifesciences.com |
Цена ао | 0.0222 |
Change price per day: | 0% (0.0222) |
---|---|
Change price per week: | 0% (0.0222) |
Change price per month: | 0% (0.0222) |
Change price per 3 month: | 0% (0.0222) |
Change price per half year: | 0% (0.0222) |
Change price per year: | -63% (0.06) |
Change price per 3 year: | -99.78% (10.21) |
Change price per year to date: | 0% (0.0222) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Vanguard Group Inc | 44098 | 0.14 |
State Street Corporation | 29600 | 0.1 |
Citadel Advisors Llc | 17458 | 0.06 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Michael G. Campbell CPA | CEO, CFO & Principal Accounting Officer | 269.11k | 1969 (56 years) |
Dr. David Soane Ph.D. | Co-Founder & Member of Scientific Advisory Board | N/A | |
Ms. Janice Marie McCourt B.S., CLP, M.B.A., R.Ph. | Chief Business Officer | N/A | 1962 (63 years) |
Address: United States, Woburn. MA, 12 Gill Street - open in Google maps, open in Yandex maps
Website: https://comeralifesciences.com
Website: https://comeralifesciences.com